Drug Interaction Information in Human Prescription Drug and Biological Product Labeling
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 21, 2024
December 11, 2024
8bdf2914-581b-4e86-8a13-dacb0ef306c0
Related Documents
Early Alzheimer’s Disease: Developing Drugs for Treatment
Guidance DocumentMarch 12, 2024Center for Drug Evaluation and Research
Geriatric Information in Human Prescription Drug and Biological Product Labeling Guidance for Industry: Draft Guidance for Industry
Guidance DocumentSeptember 15, 2020Center for Drug Evaluation and Research
Product Title and Initial US Approval in the Highlights of Prescribing Information for Human Prescription Drug and Biological Products — Content and Format Guidance for Industry
Guidance DocumentJanuary 19, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox